Format

Send to

Choose Destination
PLoS One. 2016 Jan 11;11(1):e0146638. doi: 10.1371/journal.pone.0146638. eCollection 2016.

Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations.

Author information

1
Department of Development, GENEWIZ LLC, 115 Corporate Blvd., South Plainfield, NJ, 07080, United States of America.
2
Department of Bioinformatics, GENEWIZ CN, 218 Xinghu Street, Suzhou, Jiangsu, 215123, China.

Abstract

Indexing individual template molecules with a unique identifier (UID) before PCR and deep sequencing is promising for detecting low frequency mutations, as true mutations could be distinguished from PCR errors or sequencing errors based on consensus among reads sharing same index. In an effort to develop a robust assay to detect from urine low-abundant bladder cancer cells carrying well-documented mutations, we have tested the idea first on a set of mock templates, with wild type and known mutants mixed at defined ratios. We have measured the combined error rate for PCR and Illumina sequencing at each nucleotide position of three exons, and demonstrated the power of a UID in distinguishing and correcting errors. In addition, we have demonstrated that PCR sampling bias, rather than PCR errors, challenges the UID-deep sequencing method in faithfully detecting low frequency mutation.

PMID:
26752634
PMCID:
PMC4709065
DOI:
10.1371/journal.pone.0146638
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center